These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6614583)

  • 1. Beneficial effect of papaverine plus raubasine in peripheral arterial insufficiency.
    Brevetti G; Chiariello M; Verrienti S; Spena M; Desiderati M; Condorelli M
    Angiology; 1983 Aug; 34(8):517-26. PubMed ID: 6614583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propranolol-induced reverse vascular steal in arteriopathic patients.
    Brevetti G; Chiariello M; Ferulano GP; Betocchi S; Paudice G; Lavecchia G; Abate S; Verrienti S; Condorelli M
    Angiology; 1982 Feb; 33(2):78-89. PubMed ID: 7065457
    [No Abstract]   [Full Text] [Related]  

  • 3. The papaverine test for blood flow potential of ileo-femoral arteries.
    Dedichen H
    Acta Chir Scand; 1976; 142(2):107-13. PubMed ID: 936933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of propranolol on the exercise-induced reduction of blood flow in arteriopathic patients.
    Brevetti G; Chiariello M; Rengo F; Lavecchia G; Paudice G; Condorelli M
    Angiology; 1979 Oct; 30(10):696-702. PubMed ID: 507454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evidence for the action of raubasine from a new formulation of Lamuran tablets].
    Glocke M; Grübl M; Klein K; Teufel W
    Med Klin; 1976 Sep; 71(38):1564-8. PubMed ID: 790125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study between the cardiovascular effects of cetiedil, a new vasodilator, and papaverine and aminophylline.
    Simaan JA; Aviado DM
    J Pharmacol Exp Ther; 1976 Jul; 198(1):176-86. PubMed ID: 933005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of lower limb flow and adequate intra-arterial papaverine doses to achieve maximal hyperemia in elder subjects.
    Miki K; Fujii K; Fukunaga M; Nishimura M; Horimatsu T; Saita T; Tamaru H; Imanaka T; Shibuya M; Ohyanagi M; Masuyama T
    Cardiovasc Interv Ther; 2015 Jul; 30(3):227-33. PubMed ID: 25392063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Action of raubasine (new formulation) in arterial occlusive diseases (author's transl)].
    Schütz RM; Teufel W; Glocke M
    Med Klin; 1976 Sep; 71(39):1605-10. PubMed ID: 790128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolic and blood circulation evaluation of acute ischemic cerebral accident in humans using positron emission tomography].
    Depresseux JC; Franck G; Van Cauwenberge H
    Presse Med; 1987 Jun; 16(23):1145-50. PubMed ID: 2885825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological vasodilation during reconstructive vascular surgery.
    Sonnenfeld T; Cronestrand R
    Acta Chir Scand; 1980; 146(1):9-14. PubMed ID: 6103626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasodilator action of KB-944, a new calcium antagonist.
    Morita T; Yoshino K; Kanazawa T; Ito K; Nose T
    Arzneimittelforschung; 1982; 32(9):1037-42. PubMed ID: 6890822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of raubasine on the vein tonus and venous capacity of the lower leg].
    Ehringer H; Deutsch E
    Z Kreislaufforsch; 1968 Nov; 57(11):1099-105. PubMed ID: 5710014
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of pentoxifylline and papaverine on tissue perfusion during arterial surgery.
    Niinikoski J; Vänttinen E
    Acta Chir Scand; 1988; 154(11-12):641-5. PubMed ID: 3232482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical experience with a new peripheral vasodilator agent, in which are combined raubasine, and 2 ergot alkaloids in the treatment of peripheral diabetic angiopathy].
    Martínez-López JM; Calvo-Fernández R; Garrido-Toro A; Sánchez-Cañaveral F
    Angiologia; 1973; 25(4):195-8. PubMed ID: 4717702
    [No Abstract]   [Full Text] [Related]  

  • 15. Selectivity of raubasine stereoisomers for alpha 1- and alpha 2-adrenoceptors in the rat.
    Roquebert J
    Arch Int Pharmacodyn Ther; 1986 Aug; 282(2):252-61. PubMed ID: 3021076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does pharmacologic coronary flow reserve reflect vasodilator responsiveness to increased myocardial demand in humans?
    Rossen JD; Nahser PJ; Oskarsson H; Brown RE; Winniford MD
    Coron Artery Dis; 1996 Jun; 7(6):479-84. PubMed ID: 8889365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antinoradrenergic activity of raubasine on isolated thoracic aorta and vas deferens of rat (author's transl)].
    Roquebert J; Gomond P; Demichel P
    J Pharmacol; 1981; 12(4):393-403. PubMed ID: 6119400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of papaverine and glycerylnitrate-verapamil solution as topical and intraluminal vasodilators for internal thoracic artery.
    Formica F; Ferro O; Brustia M; Corti F; Colagrande L; Bosisio E; Paolini G
    Ann Thorac Surg; 2006 Jan; 81(1):120-4. PubMed ID: 16368347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arterial flow in the lower leg correlated with plasma levels of two formulations of papaverine hydrochloride.
    Lee BY; Trainor FS
    Angiology; 1978 Apr; 29(4):310-9. PubMed ID: 655462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal perfusion: pharmacologic changes depicted with power Doppler US in an animal model.
    Durick JE; Winter TC; Schmiedl UP; Cyr DR; Starr FL; Mack LA
    Radiology; 1995 Dec; 197(3):615-7. PubMed ID: 7480728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.